EClinCloud Invites You to the 2023 China (Ningbo) Biopharmaceutical Industry Development Summit

Source: EClinCloud. Author: EClinCloud.


From March 10 to 12, 2023, the "2023 China (Ningbo) Biopharmaceutical Industry Development Summit and SAPA-China US-China Global New Drug Innovation and Clinical Development Conference" will be held at Empark Grand Hotel Hangzhou Bay in Qianwan, Ningbo.
In today's challenging domestic and global environment, optimizing global clinical development and cross-border collaboration has become a pressing challenge for pharmaceutical companies. Spanning both China and the United States, the SAPA-China US-China Global New Drug Innovation and Clinical Development Conference connects industry leaders to discuss the challenges, opportunities, and strategies in innovative drug development.
EClinCloud Keynote Presentation
Applying eCOA to Enable Patient-Centered Clinical Research
In Sub-forum 2 on "Real-World Data (RWE)" on the afternoon of March 12, Dr. Qin Long, CEO of EClinCloud, will deliver a keynote presentation titled "Applying eCOA to Enable Patient-Centered Clinical Research" from 15:20 to 15:50. Starting from the concept of COA, the presentation will detail the significance and value of eCOA for "patient-centered" clinical trials and share global regulatory perspectives on the use of eCOA alongside practical case studies. We welcome you to join the discussion and look forward to meeting you in Qianwan, Ningbo, from March 10 to 12.





*Note: For the detailed conference agenda, please follow the "Shengjie Qianyan" (盛杰前沿) WeChat official account.
EClinCloud is a technology company dedicated to clinical R&D, providing an integrated, interoperable all-in-one clinical trial cloud platform (including technology products such as CTMS, eTMF, EDC, RTSM, eCOA, and eConsent, as well as solutions such as scale management, linguistic validation, rater training, and data quality analysis) alongside clinical trial endpoint assessment technologies across therapeutic areas (including oncology, central nervous system, and ophthalmology). By combining cutting-edge technology with life sciences data, it builds a globally leading "patient-centered" SaaS cloud platform for clinical evidence support, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.



